FDA Inspection 1058599 — Pillar5 Pharma Inc.
The FDA completed an inspection of Pillar5 Pharma Inc. on May 17, 2018 in Arnprior. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Arnprior (Canada)